Modeling autosomal dominant Alzheimer's disease with machine learning

Autor: Hiroshi Mori, Laura Swisher, Sarah B. Berman, Yi Su, Aylin Dincer, Mathias Jucker, James M. Noble, Colin L. Masters, Jonathan Vöglein, Robert A. Koeppe, Bernardino Ghetti, Tammie L.S. Benzinger, DS Marcus, Jasmeer P. Chhatwal, Lisa Cash, Jason Hassenstab, Eric McDade, Randall J. Bateman, David M. Cash, Brian A. Gordon, Richard J. Perrin, Michael W. Weiner, Ari Stern, Nelly Joseph-Mathurin, Austin A. McCullough, Qing Wang, Johannes Levin, Karin L. Meeker, Deborah Koudelis, Michael J. Fulham, Jeremy F. Strain, Anne M. Fagan, Chengjie Xiong, Russ C. Hornbeck, Nick C. Fox, Adam M. Brickman, Stephen Salloway, Beau M. Ances, Clifford R. Jack, Celeste M. Karch, Carlos Cruchaga, William S. Brooks, Martin R. Farlow, Peter R. Schofield, Patrick Luckett, Hwamee Oh, John E. McCarthy, Todd A. Kuffner, William E. Klunk, John C. Morris, Shaney Flores
Rok vydání: 2021
Předmět:
Male
magnetic resonance imaging (MRI)
Epidemiology
Precuneus
genetics [Alzheimer Disease]
Disease
computer.software_genre
030218 nuclear medicine & medical imaging
Machine Learning
pathology [Alzheimer Disease]
chemistry.chemical_compound
0302 clinical medicine
autosomal dominant Alzheimer's disease (ADAD)
pathology [Atrophy]
Aniline Compounds
fluorodeoxyglucose (FDG)
medicine.diagnostic_test
Health Policy
Magnetic Resonance Imaging
Pittsburgh compound B (PiB)
Psychiatry and Mental health
medicine.anatomical_structure
Positron emission tomography
Mutation (genetic algorithm)
Female
medicine.drug
Adult
Amyloid
genetics [Mutation]
Machine learning
Article
03 medical and health sciences
Cellular and Molecular Neuroscience
Atrophy
Developmental Neuroscience
Alzheimer Disease
Fluorodeoxyglucose F18
metabolism [Fluorodeoxyglucose F18]
medicine
Humans
ddc:610
metabolism [Amyloid]
Fluorodeoxyglucose
business.industry
medicine.disease
Thiazoles
chemistry
Positron-Emission Tomography
Mutation
Neurology (clinical)
Artificial intelligence
Geriatrics and Gerontology
Pittsburgh compound B
business
computer
030217 neurology & neurosurgery
Zdroj: Alzheimer's and dementia 17(6), 1005-1016 (2021). doi:10.1002/alz.12259
Alzheimers Dement
ISSN: 1552-5279
1552-5260
Popis: INTRODUCTION: Machine learning models were used to discover novel disease trajectories for autosomal dominant Alzheimer's disease. METHODS: Longitudinal structural magnetic resonance imaging, amyloid positron emission tomography (PET), and fluorodeoxyglucose PET were acquired in 131 mutation carriers and 74 non-carriers from the Dominantly Inherited Alzheimer Network; the groups were matched for age, education, sex, and apolipoprotein e4 (APOE e4). A deep neural network was trained to predict disease progression for each modality. Relief algorithms identified the strongest predictors of mutation status. RESULTS: The Relief algorithm identified the caudate, cingulate, and precuneus as the strongest predictors among all modalities. The model yielded accurate results for predicting future Pittsburgh compound B (R2 = 0.95), fluorodeoxyglucose (R2 = 0.93), and atrophy (R2 = 0.95) in mutation carriers compared to non-carriers. DISCUSSION: Results suggest a sigmoidal trajectory for amyloid, a biphasic response for metabolism, and a gradual decrease in volume, with disease progression primarily in subcortical, middle frontal, and posterior parietal regions.
Databáze: OpenAIRE